Treatment of SARS-CoV-2 relapse with remdesivir and neutralizing antibodies cocktail in a patient with X-linked agammaglobulinaemia.
COVID-19
Casirivimab
Imdevimab
Immunocompromised
Monoclonal antibodies
Neutralizing antibodies
Remdesivir
SARS-CoV-2
XLA
Journal
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933
Informations de publication
Date de publication:
Sep 2021
Sep 2021
Historique:
received:
18
04
2021
revised:
06
07
2021
accepted:
23
07
2021
pubmed:
1
8
2021
medline:
29
9
2021
entrez:
31
7
2021
Statut:
ppublish
Résumé
During the coronavirus disease 2019 (COVID-19) pandemic, patients with humoral immunodeficiency are at higher risk of developing chronic infection and having a negative outcome. Few data are available on therapeutic options for this population. This case report discusses the treatment of disease relapse with remdesivir and monoclonal antibodies in an adult patient with X-linked agammaglobulinaemia.
Identifiants
pubmed: 34332085
pii: S1201-9712(21)00619-6
doi: 10.1016/j.ijid.2021.07.064
pmc: PMC8317455
pii:
doi:
Substances chimiques
Antibodies, Neutralizing
0
Antibodies, Viral
0
remdesivir
3QKI37EEHE
Adenosine Monophosphate
415SHH325A
Alanine
OF5P57N2ZX
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
338-340Informations de copyright
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.
Déclaration de conflit d'intérêts
Conflict of interest statement None declared.
Références
Cureus. 2020 Nov 25;12(11):e11701
pubmed: 33391934
J Infect Dis. 2020 Sep 1;222(7):1103-1107
pubmed: 32702095
Pediatr Allergy Immunol. 2020 Jul;31(5):565-569
pubmed: 32319118
J Allergy Clin Immunol Pract. 2020 Nov - Dec;8(10):3594-3596.e3
pubmed: 32947026
Int J Infect Dis. 2021 Mar;104:379-381
pubmed: 33359065
N Engl J Med. 2021 Jan 21;384(3):238-251
pubmed: 33332778
J Clin Immunol. 2021 Jul;41(5):923-925
pubmed: 33547548
Nat Commun. 2020 Dec 14;11(1):6385
pubmed: 33318491
Immunity. 2021 Feb 9;54(2):340-354.e6
pubmed: 33567252
J Allergy Clin Immunol Pract. 2020 Sep;8(8):2793-2795
pubmed: 32652231
N Engl J Med. 2020 Dec 3;383(23):2291-2293
pubmed: 33176080
J Infect Dev Ctries. 2020 Nov 30;14(11):1248-1251
pubmed: 33296336
Nature. 2021 Apr;592(7853):277-282
pubmed: 33545711